Clal Biotechnology reported ILS5.73M in Cash and Equivalent for its fiscal quarter ending in December of 2023.


Cash And Equivalent Change Date
Clal Biotechnology ILS 5.73M 1.71M Dec/2023
Compugen USD 6.47M 11.76M Jun/2025
Life Technologies USD 17.22M 6.16M Jun/2025
RedHill Biopharma USD 4.62M 2.66M Dec/2024